142 related articles for article (PubMed ID: 37032481)
1. Diagnostics of ovarian cancer via metabolite analysis and machine learning.
Yao JZ; Tsigelny IF; Kesari S; Kouznetsova VL
Integr Biol (Camb); 2023 Apr; 15():. PubMed ID: 37032481
[TBL] [Abstract][Full Text] [Related]
2. Recognition of early and late stages of bladder cancer using metabolites and machine learning.
Kouznetsova VL; Kim E; Romm EL; Zhu A; Tsigelny IF
Metabolomics; 2019 Jun; 15(7):94. PubMed ID: 31222577
[TBL] [Abstract][Full Text] [Related]
3. Diagnostics of Thyroid Cancer Using Machine Learning and Metabolomics.
Kuang A; Kouznetsova VL; Kesari S; Tsigelny IF
Metabolites; 2023 Dec; 14(1):. PubMed ID: 38248814
[TBL] [Abstract][Full Text] [Related]
4. Identification of Potential Biomarkers and Metabolic Profiling of Serum in Ovarian Cancer Patients Using UPLC/Q-TOF MS.
Yang W; Mu T; Jiang J; Sun Q; Hou X; Sun Y; Zhong L; Wang C; Sun C
Cell Physiol Biochem; 2018; 51(3):1134-1148. PubMed ID: 30476914
[TBL] [Abstract][Full Text] [Related]
5. GC-MS based metabolite fingerprinting of serous ovarian carcinoma and benign ovarian tumor.
Eroglu EC; Kucukgoz Gulec U; Vardar MA; Paydas S
Eur J Mass Spectrom (Chichester); 2022 Feb; 28(1-2):12-24. PubMed ID: 35503418
[TBL] [Abstract][Full Text] [Related]
6. Usefulness of Amino Acid Profiling in Ovarian Cancer Screening with Special Emphasis on Their Role in Cancerogenesis.
Plewa S; Horała A; Dereziński P; Klupczynska A; Nowak-Markwitz E; Matysiak J; Kokot ZJ
Int J Mol Sci; 2017 Dec; 18(12):. PubMed ID: 29258187
[TBL] [Abstract][Full Text] [Related]
7. Top-Down Proteomics of Human Saliva, Analyzed with Logistic Regression and Machine Learning Methods, Reveal Molecular Signatures of Ovarian Cancer.
Scebba F; Salvadori S; Cateni S; Mantellini P; Carozzi F; Bisanzi S; Sani C; Robotti M; Barravecchia I; Martella F; Colla V; Angeloni D
Int J Mol Sci; 2023 Oct; 24(21):. PubMed ID: 37958700
[TBL] [Abstract][Full Text] [Related]
8. Metabonomics study on orthotopic transplantion mice model of colon cancer treated with Astragalus membranaceus-Curcuma wenyujin in different proportions via UPLC-Q-TOF/MS.
Sun R; Gu J; Chang X; Liu F; Liang Y; Yang X; Liang L; Tang D
J Pharm Biomed Anal; 2021 Jan; 193():113708. PubMed ID: 33129117
[TBL] [Abstract][Full Text] [Related]
9. Finding distinctions between oral cancer and periodontitis using saliva metabolites and machine learning.
Kouznetsova VL; Li J; Romm E; Tsigelny IF
Oral Dis; 2021 Apr; 27(3):484-493. PubMed ID: 32762095
[TBL] [Abstract][Full Text] [Related]
10. Combined network analysis and machine learning allows the prediction of metabolic pathways from tomato metabolomics data.
Toubiana D; Puzis R; Wen L; Sikron N; Kurmanbayeva A; Soltabayeva A; Del Mar Rubio Wilhelmi M; Sade N; Fait A; Sagi M; Blumwald E; Elovici Y
Commun Biol; 2019; 2():214. PubMed ID: 31240252
[TBL] [Abstract][Full Text] [Related]
11. Identification of novel candidate plasma metabolite biomarkers for distinguishing serous ovarian carcinoma and benign serous ovarian tumors.
Buas MF; Gu H; Djukovic D; Zhu J; Drescher CW; Urban N; Raftery D; Li CI
Gynecol Oncol; 2016 Jan; 140(1):138-44. PubMed ID: 26521694
[TBL] [Abstract][Full Text] [Related]
12. Metabolomics and Machine Learning Identify Metabolic Differences and Potential Biomarkers for Frequent Versus Infrequent Gout Flares.
Wang M; Li R; Qi H; Pang L; Cui L; Liu Z; Lu J; Wang R; Hu S; Liang N; Tao Y; Dalbeth N; Merriman TR; Terkeltaub R; Yin H; Li C
Arthritis Rheumatol; 2023 Dec; 75(12):2252-2264. PubMed ID: 37390372
[TBL] [Abstract][Full Text] [Related]
13. A personalized probabilistic approach to ovarian cancer diagnostics.
Ban D; Housley SN; Matyunina LV; McDonald LD; Bae-Jump VL; Benigno BB; Skolnick J; McDonald JF
Gynecol Oncol; 2024 Mar; 182():168-175. PubMed ID: 38266403
[TBL] [Abstract][Full Text] [Related]
14. Using machine learning to predict ovarian cancer.
Lu M; Fan Z; Xu B; Chen L; Zheng X; Li J; Znati T; Mi Q; Jiang J
Int J Med Inform; 2020 Sep; 141():104195. PubMed ID: 32485554
[TBL] [Abstract][Full Text] [Related]
15. Serum Metabolomics Identifies Dysregulated Pathways and Potential Metabolic Biomarkers for Hyperuricemia and Gout.
Shen X; Wang C; Liang N; Liu Z; Li X; Zhu ZJ; Merriman TR; Dalbeth N; Terkeltaub R; Li C; Yin H
Arthritis Rheumatol; 2021 Sep; 73(9):1738-1748. PubMed ID: 33760368
[TBL] [Abstract][Full Text] [Related]
16. A screening test proposal for congenital defects based on maternal serum metabolomics profile.
Troisi J; Lombardi M; Scala G; Cavallo P; Tayler RS; Symes SJK; Richards SM; Adair DC; Fasano A; McCowan LM; Guida M
Am J Obstet Gynecol; 2023 Mar; 228(3):342.e1-342.e12. PubMed ID: 36075482
[TBL] [Abstract][Full Text] [Related]
17. Automated Machine Learning and Explainable AI (AutoML-XAI) for Metabolomics: Improving Cancer Diagnostics.
Bifarin OO; Fernández FM
J Am Soc Mass Spectrom; 2024 May; ():. PubMed ID: 38690775
[TBL] [Abstract][Full Text] [Related]
18. Complex metabolic interactions between ovary, plasma, urine, and hair in ovarian cancer.
Zhong X; Ran R; Gao S; Shi M; Shi X; Long F; Zhou Y; Yang Y; Tang X; Lin A; He W; Yu T; Han TL
Front Oncol; 2022; 12():916375. PubMed ID: 35982964
[TBL] [Abstract][Full Text] [Related]
19. Assessment of peritoneal microbial features and tumor marker levels as potential diagnostic tools for ovarian cancer.
Miao R; Badger TC; Groesch K; Diaz-Sylvester PL; Wilson T; Ghareeb A; Martin JA; Cregger M; Welge M; Bushell C; Auvil L; Zhu R; Brard L; Braundmeier-Fleming A
PLoS One; 2020; 15(1):e0227707. PubMed ID: 31917801
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
